A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

被引:0
|
作者
Patrizia Vici
Giuseppe Colucci
Francesco Giotta
Domenico Sergi
Gianfranco Filippelli
Pasquale Perri
Claudio Botti
Enrico Vizza
Armando Carpino
Laura Pizzuti
Agnese Latorre
Diana Giannarelli
Massimo Lopez
Luigi Di Lauro
机构
[1] Regina Elena National Cancer Institute,Division of Medical Oncology B
[2] Oncologic Institute,Department of Medical and Experimental Oncology
[3] Division of Medical Oncology,Division of Surgery A
[4] S. Francesco Hospital,Division of Gynecological Oncology
[5] Regina Elena National Cancer Institute,Cardiologic Unit
[6] Regina Elena National Cancer Institute,Biostatistics Unit
[7] Regina Elena National Cancer Institute,undefined
[8] Regina Elena National Cancer Institute,undefined
关键词
Anthracyclines; Lapatinib; Pegylated Liposomal Doxorubicin; Neutropenic Fever; Advanced Breast Cancer Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
    Vici, Patrizia
    Colucci, Giuseppe
    Giotta, Francesco
    Sergi, Domenico
    Filippelli, Gianfranco
    Perri, Pasquale
    Botti, Claudio
    Vizza, Enrico
    Carpino, Armando
    Pizzuti, Laura
    Latorre, Agnese
    Giannarelli, Diana
    Lopez, Massimo
    Di Lauro, Luigi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [2] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
  • [3] A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer
    Hegg, R
    Costa, MA
    Perdicaris, M
    Delgado, GL
    Cabral, S
    Malzyner, A
    Caponero, R
    Yamagushi, N
    Novaes, N
    Anelli, A
    Correa, M
    Nader, L
    Andrade, C
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 16 (04) : 225 - 234
  • [4] PHASE-II TRIAL OF VINORELBINE DOXORUBICIN AS FIRST-LINE THERAPY OF ADVANCED BREAST-CANCER
    SPIELMANN, M
    DORVAL, T
    TURPIN, F
    ANTOINE, E
    JOUVE, M
    MAYLEVIN, F
    LACOMBE, D
    ROUESSE, J
    POUILLART, P
    TURSZ, T
    MERLE, S
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) : 1764 - 1770
  • [5] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] NON PEGYLATED LIPOSOMAL DOXORUBICIN (MYOCET) PLUS VINORELBINE VERSUS MYOCET PLUS CYCLOPHOSPHAMIDE AS FIRST LINE IN LOCALLY ADVANCED (LABC) OR METASTATIC BREAST CANCER (MBC): A RANDOMIZED MULTICENTER PHASE II TRIAL
    Lorusso, V
    Leo, S.
    Forcignano, R.
    Giotta, F.
    Bordonaro, R.
    Filippelli, G.
    Del Prete, S.
    Maiello, E.
    Gebbia, V
    Pisconti, S.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2009, 20
  • [7] Non Pegylated Liposomal Doxorubicin (Myocet) Plus Vinorelbine Versus Myocet Plus Cyclophosphamide as First Line in Locally Advanced (Labc) or Metastatic Breast Cancer (Mbc): A Randomized Multicenter Phase II Trial
    Lorusso, V.
    Leo, S.
    Forcignano, R.
    Giotta, F.
    Bordonaro, R.
    Filippelli, G.
    Del Prete, S.
    Maiello, E.
    Gebbia, V.
    Pisconti, S.
    Colucci, G.
    ONCOLOGY, 2009, 77 : 151 - 151
  • [8] Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer - A phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    ACTA ONCOLOGICA, 2003, 42 (04) : 309 - 314
  • [9] A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer
    Chow, Louis Wing-Cheong
    Yip, Adrian Yun-San
    Lang, Brian Hung-Hin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (02): : 133 - 138
  • [10] First-line treatment with epirubicin and vinorelbine in metastatic breast cancer
    Vici, P
    Colucci, G
    Gebbia, V
    Amodio, A
    Giotta, F
    Belli, F
    Conti, F
    Gebbia, N
    Pezzella, G
    Valerio, MR
    Brandi, M
    Pisconti, S
    Durini, E
    Giannarelli, D
    Lopez, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2689 - 2694